The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Update on safety and efficacy of a phase 1/2 of SNS-301 added to pembrolizumab in patients with advanced squamous cell carcinoma of the head and neck (SCCHN).
 
Alain Patrick Algazi
Stock and Other Ownership Interests - OncoSec; Valitor
Consulting or Advisory Role - Array BioPharma; OncoSec; Regeneron; Valitor
Research Funding - Acerta Pharma (Inst); Amgen (Inst); AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); Dynavax Technologies (Inst); Genentech (Inst); Idera (Inst); Incyte (Inst); Merck (Inst); Novartis (Inst); OncoSec (Inst); Oncosec (Inst); Sensei Biotherapeutics (Inst); Tessa Therapeutics (Inst)
Travel, Accommodations, Expenses - OncoSec
(OPTIONAL) Uncompensated Relationships - Merck; Sensei Biotherapeutics
 
Dhaval Shah
No Relationships to Disclose
 
William Smith
Research Funding - Alliance for Cancer Gene Therapy
 
Timothy J. Panella
No Relationships to Disclose
 
Dong Moon Shin
No Relationships to Disclose
 
Justine Yang Bruce
Leadership - ImageMoverMD (I)
Stock and Other Ownership Interests - ImageMoverMD (I)
Consulting or Advisory Role - Genzyme
Research Funding - Incyte (Inst); Kura Oncology (Inst); Lilly (Inst); Macrogenics (Inst); Merck (Inst); Pfizer (Inst); Sensei Biotherapeutics (Inst)
 
Ramzi Melhem
Employment - Sensei Biotherapeutics
Stock and Other Ownership Interests - Sensei Biotherapeutics
 
Jean S. Campbell
Employment - Sensei Biotherapeutics
Stock and Other Ownership Interests - Alvaxa Biosciences; Sensei Biotherapeutics
Consulting or Advisory Role - Sensei Biotherapeutics
Patents, Royalties, Other Intellectual Property - OncoSec; Sensei Biotherapeutics
 
Lauren Abell
Employment - Sensei Biotherapeutics
Stock and Other Ownership Interests - Sensei Biotherapeutics
 
Marie-Louise Fjaellskog
Employment - Merus; Sensei Biotherapeutics
Leadership - Biovica
Stock and Other Ownership Interests - Infinity Pharmaceuticals; Merus; Sensei Biotherapeutics
 
John K. Celebi
Employment - Sensei Biotherapeutics
Leadership - Sensei Biotherapeutics
Stock and Other Ownership Interests - Sensei Biotherapeutics; X4 Pharma
Travel, Accommodations, Expenses - Sensei Biotherapeutics
 
Robert Hamilton Pierce
Employment - Sensei Biotherapeutics
Leadership - Alvaxa Biosciences (I)
Stock and Other Ownership Interests - Alvaxa Biosciences; Calithera Biosciences (I); Celgene (I); Five Prime Therapeutics (I); Immunomic Therapeutics; OncoSec; Sensei Biotherapeutics
Consulting or Advisory Role - Abbvie; Apros Therapeutics (I); Calithera Biosciences; Genexine (I); Ideaya Biosciences (I); IgM Biosciences (I); Immune Design (I); Juno Therapeutics (I); Neoleukin Therapeutics; Nkarta (I); Pulse Biosciences; Seagen (I)
Research Funding - AstraZeneca/MedImmune (Inst); Exicure (Inst); Immunomic Therapeutics (Inst); Incyte (Inst); Juno Therapeutics (Inst); Minerva Neurosciences (Inst); Pulse Biosciences (Inst); Sensei Biotherapeutics (Inst); X4 Pharma (Inst)
Travel, Accommodations, Expenses - Immunomic Therapeutics; Immunomic Therapeutics; Pulse Biosciences; Sensei Biotherapeutics
 
Ann Wild Gramza
Consulting or Advisory Role - Blueprint Medicines; Eisai
Speakers' Bureau - Eisai